![Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity - ScienceDirect Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120300483-fx1.jpg)
Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity - ScienceDirect
![Vaccines | Free Full-Text | Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection Vaccines | Free Full-Text | Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection](https://pub.mdpi-res.com/vaccines/vaccines-09-01333/article_deploy/html/images/vaccines-09-01333-g001-550.jpg?1637049091)
Vaccines | Free Full-Text | Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
![Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abi6950/asset/24c449b8-b99e-48a1-9d8d-a844b2627db9/assets/graphic/abi6950-f1_v2.jpeg)
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
![Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/6bfe121f-8f79-4f98-a30f-d5d956b5a71f/gr1_lrg.gif)
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health
Effectiveness of Hepatitis B Vaccination in Babies Born to Hepatitis B Surface Antigen-Positive Mothers in Italy
![The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges - ScienceDirect The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1876034122000028-fx1.jpg)
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges - ScienceDirect
![Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Nature Communications Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-29015-y/MediaObjects/41467_2022_29015_Fig1_HTML.png)
Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Nature Communications
![A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures - eClinicalMedicine A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures - eClinicalMedicine](https://www.thelancet.com/cms/attachment/d73abe36-64ee-41db-8078-2ef43d6b11dc/gr1_lrg.jpg)
A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures - eClinicalMedicine
Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepati
![A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model: Molecular Therapy - Oncolytics A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/a3ff64c5-c6dd-40a0-b4b0-8db796f9a287/gr1.jpg)